AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionRockefeller Capital Management L.P.
Latest Disclosed Ownership911,994 shares
Latest Disclosed Value $ 198,349,853
Rockefeller Capital Management L.P. reports 3.21% increase in ownership of 4AB / AbbVie Inc.

On May 14, 2026 - Rockefeller Capital Management L.P. filed a 13F-HR form disclosing ownership of 911,994 shares of AbbVie Inc. (BG:4AB) valued at $198,349,853 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on March 16, 2026 disclosing 883,644 shares of AbbVie Inc.. This represents a change in shares of 3.21% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ABBVIE COM 00287Y109 911,994 28,350 3.21 198,350 -1.76 0.3517
2026-03-16 2025-12-31 13F/A-1 ABBVIE COM 00287Y109 883,644 81,375 10.14 201,904 8.69 0.3636
2026-02-14 2025-12-31 13F ABBVIE COM 00287Y109 2,581,894 1,779,625 202,079 0.1845
2025-11-14 2025-09-30 13F ABBVIE COM 00287Y109 802,269 41,288 5.43 185,758 31.51 0.3634
2025-08-14 2025-06-30 13F/A-1 ABBVIE COM 00287Y109 760,981 19,098 2.57 141,254 -9.13 0.3098
2025-08-08 2025-06-30 13F ABBVIE COM 00287Y109 760,399 18,516 141,146 0.1779
2025-05-14 2025-03-31 13F ABBVIE COM 00287Y109 741,883 -21,494 -2.82 155,440 14.58 0.3837
2025-02-13 2024-12-31 13F ABBVIE COM 00287Y109 763,377 -66,500 -8.01 135,659 -17.21 0.3514
2024-11-14 2024-09-30 13F ABBVIE COM 00287Y109 829,877 16,917 2.08 163,862 17.50 0.4411
2024-08-12 2024-06-30 13F ABBVIE COM 00287Y109 812,960 14,508 1.82 139,454 -4.09 0.3964
2024-05-14 2024-03-31 13F ABBVIE COM 00287Y109 798,452 56,328 7.59 145,398 26.43 0.4244
2024-02-14 2023-12-31 13F ABBVIE COM 00287Y109 742,124 63,616 9.38 115,007 13.71 0.3843
2023-11-14 2023-09-30 13F ABBVIE COM 00287Y109 678,508 47,800 7.58 101,140 21.48 0.3901
2023-08-14 2023-06-30 13F ABBVIE COM 00287Y109 630,708 6,220 1.00 83,255 83,994.95 0.3225
2023-05-16 2023-03-31 13F ABBVIE COM 00287Y109 624,488 -16,261 -2.54 100 -99.90 0.4280
2023-03-06 2022-12-31 13F ABBVIE COM 00287Y109 640,749 -1,491 -0.23 103,549 20.13 0.5204
2022-11-02 2022-09-30 13F ABBVIE COM 00287Y109 642,240 137,854 27.33 86,194 11.58 0.4455
2022-08-12 2022-06-30 13F ABBVIE COM 00287Y109 504,386 74,757 17.40 77,250 10.92 0.4105
2022-05-13 2022-03-31 13F ABBVIE COM 00287Y109 429,629 8,281 1.97 69,645 22.08 0.3359
2022-02-14 2021-12-31 13F ABBVIE COM 00287Y109 421,348 16,429 4.06 57,049 30.62 0.2662
2021-11-12 2021-09-30 13F ABBVIE COM 00287Y109 404,919 51,054 14.43 43,677 9.58 0.2295
2021-08-10 2021-06-30 13F ABBVIE COM 00287Y109 353,865 61,752 21.14 39,857 26.09 0.2245
2021-05-11 2021-03-31 13F ABBVIE COM 00287Y109 292,113 22,357 8.29 31,611 9.37 0.2139
2021-02-12 2020-12-31 13F ABBVIE COM 00287Y109 269,756 40,665 17.75 28,902 44.05 0.2189
2020-11-13 2020-09-30 13F ABBVIE COM 00287Y109 229,091 38,689 20.32 20,064 7.33 0.1880
2020-08-12 2020-06-30 13F ABBVIE COM 00287Y109 190,402 31,350 19.71 18,694 54.27 0.1956
2020-05-12 2020-03-31 13F ABBVIE COM 00287Y109 159,052 23,739 17.54 12,118 1.14 0.1590
2020-02-07 2019-12-31 13F ABBVIE COM 00287Y109 135,313 46,515 52.38 11,982 78.22 0.1494
2019-11-12 2019-09-30 13F ABBVIE COM 00287Y109 88,798 31,639 55.35 6,723 61.73 0.0912
2019-08-09 2019-06-30 13F ABBVIE COM 00287Y109 57,159 -4,049 -6.62 4,157 -15.73 0.0580
2019-05-10 2019-03-31 13F ABBVIE COM 00287Y109 61,208 8,057 15.16 4,933 0.67 0.0703
2019-02-12 2018-12-31 13F ABBVIE COM 00287Y109 53,151 13,156 32.89 4,900 29.56 0.0859
2018-11-02 2018-09-30 13F AbbVie Common 00287Y109 39,995 -2,004 -4.77 3,782 -2.80 0.0574
2018-07-31 2018-06-30 13F AbbVie Common 00287Y109 41,999 226 0.54 3,891 -1.59 0.0634
2018-05-09 2018-03-31 13F AbbVie Common 00287Y109 41,773 41,773 3,954 0.0653
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.